Delta 9 Cannabis Secures Rare Manitoba Conditional Approval


Ryan Allway

March 8th, 2018

Exclusive, News, Top News


Canada’s cannabis industry is projected to reach up to C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational adult-use cannabis later this year. While the federal government finalizes the legislation, individual provinces have also been working out how they will handle the cultivation, distribution, and sale of cannabis. These rules have created several opportunities among publicly-traded companies in the space.

Delta 9 Cannabis Inc. (TSX-V: NINE) is one licensed producer that could benefit from these new provincial rules. As one of just four groups conditionally approved in Manitoba, the company is uniquely positioned to capitalize on a market that management believes could be worth between $300 million and $500 million per year. Investors may want to take a closer look at the stock given the company’s new conditional approval and partnership with an industry leader.

Manitoba Decides on Four LPs

Manitoba has conditionally approved four groups that will operate the province’s cannabis retail after receiving over one hundred applications. Each of the four groups submitted proposals that met the criteria outlined in the government’s RFP, but official acceptance of the proposals is conditional on them reaching all of the necessary agreements and providing the required documents that were outlined in the government’s RFP.

The four groups that were conditionally approved include:

  • Delta 9 Cannabis and Canopy Growth Corp. (TSX: WEED)
  • National Access Cannabis and Manitoba First Nations
  • Tokyo Smoke and B.O.B. Headquarters
  • Avana Canada, Fisher River Cree Nation, Chippewas of the Thames of Ontario, MediPharm Labs, and Native Roots Dispensary (a U.S. retailer)

The group applications were evaluated by an independent third party to ensure that the process was fair and equitable. Over the coming weeks, the Manitoba government will work with these groups on the next stages of due diligence, including the number of locations and retail stores each group will be permitted to operate under provincial licensing agreements.

Delta 9’s Agreement with Canopy

Delta 9 Cannabis and Canopy Growth teamed up to build and operate a chain of retail stores throughout Manitoba. The first location has already been built in the Osborne Village area of Winnipeg and has been operating for several months as a resource center and clinic. In addition, the agreement calls for Delta 9’s products to be distributed through Canopy Growth outlets in other provinces and through its Tweed Main Street online sales portal.

“It is hard to overstate how important this award is for our company, our shareholders, and the future of the legal cannabis industry in Manitoba,” said Delta 9 Cannabis CEO John Arbuthnot in a recent press release. “As the only Manitoba producer licensed to sell cannabis, and partnered with the world’s largest cannabis company, we feel we are uniquely situated to serve the Manitoba market with both quantity and quality of product.”

Management estimates that Manitoba’s cannabis market could be worth between $300 million and $500 million per year. In addition to leveraging Canopy Growth’s significant scale, the company also continues to advance its own construction project that’s coming in under budget. Management believes that it is fully funded to build 600 of its self-designed “grow pods”, which could increase its cannabis production to 17,500 kilograms per year.

Looking Ahead

Delta 9 Cannabis Inc. (TSX-V: NINE) is one of just four groups approved to open retail locations in Manitoba’s market, which management believes could be worth $300 million to $500 million per year. Through its partnership with Canopy Growth, the company is uniquely positioned to scale up in the new recreational adult-use market while simultaneously building up its own production capacity using its innovative grow pods.

For more information, visit the company’s website at www.delta9.ca.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please see our disclaimer below and follow the link to view our full disclosure outlining compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading